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1. Introduction 
Aging is a multifunctional disorder that leads to cell death, tumors and the other diseases. 
Accumulation of improper molecular information during aging results in loss of functions 
in cells and tissues. The ovary is one of the first organs to age; women lose their fertility in 
their middle age (around 35 years old) and their fecundity expires soon thereafter (at more 
than 40 years old) (Baird et al. 2005; Alviggi et al. 2009). Although the exact mechanism 
underlying female reproductive aging remains unclear, common features among species, 
including loss of the ovarian follicle pool, disability of chromosome segregation leading to 
aneuploidy, and increasing mitochondrial dysfunctions, have been reported (Djahanbakhch 
et al. 2007). These changes are largely associated with the unique mechanism of oogenesis. 
Oocytes that mitotically proliferate during fetal development are stored in the ovaries 
without further proliferation and are repeatedly ovulated after they enter meiosis. 
Accordingly, oocytes that are stored for a longer duration gradually lose their functions 
because the ovarian microenvironment changes with aging. 
Ovulation is known to produce reactive oxygen species (ROS) in the ovaries. Although ROS 
are toxic and sometimes lethal for any cell types, they are even necessary for proper 
ovulation because direct administration of ROS scavengers, N-acetylcysteine and 
dibutylhydroxytoluene, into mouse bursa blocked ovulation and hydrogen peroxide-
assisted ovulation by functioning like luteinizing hormone (LH) (Shkolnik et al. 2011). 
Nevertheless, repeated exposure of stored oocytes to ROS at each ovulation results in loss of 
the integrity of these stored oocytes (Chao et al. 2005; Miyamoto et al. 2010). Oxidative stress 
is well known to damage macromolecules and cellular components, e.g., mitochondrial 
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desensitization, mitochondrial DNA mutation, irregular DNA methylation, and improper 
chromosome segregation. In addition, these changes affect the hormonal regulation; losing 
ovarian endocrine cells by both ovulation and oxidative damages alters the hormonal 
feedback system in the pituitary-gonad axis.  
From a clinical viewpoint, age-associated infertility is not a small part in all the infertile 
patients. However, lack of knowledge regarding the aging mechanism hampers clinical 
approaches for treatment of aged women. Here we review recent findings on female 
reproductive aging and propose possible treatment options for age-associated infertility.  
2. The prenatal and postnatal pathways of oogenesis 
The debate on the duration of oogenesis in the whole life of females had been sealed for 
decades. However, recent reports on postnatal oogenesis and germline stem cells have 
resumed this debate. Herein we describe the prenatal and postnatal pathways of oogenesis 
from the viewpoint of reproductive aging. 
2.1 The prenatal pathway of oogenesis 
In the early stage of embryogenesis, primordial germ cells (PGCs) – from which oocytes 
originate – migrate from the dorsal yolk sac into the genital ridge where gonads would be 
formed (De Felici & Siracusa 1985). In mice, the germ cells originated from the proximal 
epiblast of the egg cylinder at embryonic day 5.5 to 6 in response to Bmp4 and Bmp8b 
signaling (Ying et al. 2001). In humans, this process occurs during the first month of 
gestation (Djahanbakhch et al. 2007). Then, the cells undergo mitosis; however the number of 
PGCs is highly limited at this time point. The PGCs proliferate rapidly, and approximately 7 
× 106 oogonia are eventually formed at 6–8 weeks of gestation in humans. During this 
process, transforming growth factor- (TGF- family members, including activins, BMPs, 
and TGF-1, support the proliferation of PGCs (Godin & Wylie 1991; Richards et al. 1999; 
Farini et al. 2005; Childs et al. 2010). Activins and their receptors are highly expressed in 
human oogonia at later stages of gestation and activin A supports the proliferation of 
oogonia in vitro (Martins da Silva et al. 2004). The oogonia then enter meiosis at 11–12 weeks 
of gestation in humans (Gondos et al. 1986).  
After oogonia are enclosed by the granulosa cells and primordial follicles are formed, a 
number of oocytes are destined to die without contributing to reproduction during meiotic 
prophase I (Hussein 2005; Ghafari et al. 2007). More than one-third of all pachytene oocytes 
are proapoptotic, and a high frequency of atresia is observed between midterm and birth in 
the human ovaries (Speed 1988; De Pol et al. 1997). The large-scale loss of the ovarian follicle 
pool has been estimated to be more than 80% in humans (Martins da Silva et al. 2004).  
Several paracrine factors that affect oocyte survival have been reported (Fig. 1). For example, 
growth factors including KIT ligand, leukocyte inhibitory factor (LIF), BMP-4, SDF-1, and 
basic FGF have been shown to be able to sustain the survival and proliferation of PGCs in 
the absence of somatic cell support (Farini et al. 2005). In addition, SCF, insulin-like growth 
factor I (IGF-I), and LIF have been found to assist the survival of germ cells in mice (Morita 
et al. 1999; Gu et al. 2009). In contrast, tumor necrosis factor- (TNF-) promotes apoptosis at 
the neonatal stage in rats (Marcinkiewicz et al. 2002; Morrison & Marcinkiewicz 2002). In 
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addition, intracellular factors determine the fate of oocytes. Members of the B cell 
lymphoma/leukemia (BCL) protein family, including BCL-2 and BAX, have been suggested 
to be involved in this process (Felici et al. 1999); BCL-2 is expressed in oocytes undergoing 
meiosis, and its expression is stable during meiotic prophase I, whereas upregulation of 
BAX is observed in oocytes undergoing apoptosis. Genetic inactivation (knockout) of BAX 
in mice resulted in higher number of germ cells in peri-natal ovaries compared with wild-
type or heterozygous mice (Alton & Taketo 2007). Moreover, NANOS3 and DND1 protect 
PGCs from apoptosis (Tsuda et al. 2003; Youngren et al. 2005). Although the biological basis 
of the oocyte selection has not been completely understood, prenatal loss of oocytes may 
occur because of exclusion of accumulated mutations in mitochondria, clearance of lethal 
errors arising during the mitosis or meiotic prophase, or increased survival of some oocytes 
within a particular sibling “nest“ (Ghafari et al. 2007). An imbalance between cell death and 
survival signaling would result in an abnormal number of follicles that would be stored in 
the ovaries at this stage; higher frequency of oocyte death that is a result of atresia 
eventually leads to irreversible premature ovarian failure (Krysko et al. 2008). Therefore, the 
number of oocytes that are stored prenatally must be extremely important for the 
subsequent reproductive period. 
 
Fig. 1. Determinants of the maximum number of oocytes in the entire life of an organism. 
Several growth factors, including activins, BMPs, SCF, IGF-1, and LIF, promote proliferation 
of PGCs and oocyte growth, whereas TNF- induces oocyte death. The number of follicles 
at this stage is determined by the balance between survival and death signaling. In addition, 
the intracellular balance between BCL-2 and BAX determines oocyte survival and death. 
NANOS3 is another anti-apoptotic molecule found in PGCs.  
2.2 The postnatal pathway of oogenesis 
Can oocytes be newly produced in adult ovaries? This ancient question arises with the 
observation of adult mice whose ovaries contain mitotically active germ cells (Johnson et al. 
2004). This finding led to the hypothesis that oocytes can be generated from sources other 
than those prenatally stored in the ovaries. A possible origin of postnatal oocytes has been 
reported to be a specific set of bone marrow cells or peripheral blood cells expressing 
germline markers (Johnson et al. 2005). Johnson et al. reported that both bone marrow and 
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peripheral blood transplantations restored oocytes in mice that lost all oocytes by 
chemotherapy. However, another study claimed that fresh mature oocytes could not be 
obtained when wild-type and GFP-transgenic mice were parabiotically jointed to establish 
blood crossover (Eggan et al. 2006). Later, this report was supported when transplanted 
bone marrow cells could be transformed only into immature oocytes (Lee et al. 2007; Tilly et 
al. 2009). Moreover, other reports emphasized the possibility that putative germline stem 
cells exist inside and outside the ovaries in some species. In pigs, fetal skin cells have been 
reported to contribute to the generation of oocytes (Dyce et al. 2006). The ovarian surface 
epithelium (OSE) cells are another candidate for the origin of oocyte in adult human and rat 
ovaries (Bukovsky et al. 2008; Parte et al. 2011), although the candidate cells in OSE may 
originate from bone marrow cells. In addition, a pancreatic stem cell line seems to 
differentiate into oocyte-like cells in rats (Danner et al. 2007). Unfortunately, none of these 
germline stem cells have contributed to the production of the next generation. Furthermore, 
the molecular mechanisms underlying postnatal oogenesis of putative germline stem cells 
continue to be a black box. Even so, these cells might be useful for clinical applications if a 
specific condition in which mature fertile oocytes are postnatally generated is elucidated. 
Although these findings are fascinating, the following questions are arising. 
1. Can the germline stem cells participate in oogenesis over the entire life of females? 2. Do 
other germline stem cells exist? 3. Is there a specific condition in which the germline stem 
cells participate in oogenesis? 4. How many oocytes are generated in the ovaries through 
postnatal oogenesis? 5. Are the factors that assist postnatal oogenesis the same as those that 
assist in prenatal oogenesis? 6. What is the exact role of postnatal oogenesis? Unfortunately, 
we still have to wait many years to obtain sufficient data to answer these questions. 
3. Modification of oocyte quantities and qualities during aging 
The common physiology of the ovaries during aging among species includes loss of the 
ovarian follicle pool, chromosomal abnormalities and cytoplasmic abnormalities (Fig. 2). All 
these changes may be inevitable and are associated with declining oocyte quality. Here 
recent findings regarding the alterations in oocyte quantities and qualities are discussed.  
 
Fig. 2. Common features of female reproductive aging in mammals. Loss of the ovarian follicle 
pool is caused partly by characteristic oogenesis and partly by ovulation, thereby leading to 
hormonal imbalance. Chromosomal aberrancy and cytoplasmic abnormalities are possibly 
induced by longer exposures of stored oocytes to oxidative stress. Recently, these 
abnormalities have been shown to be reversible by calorie restriction (Selesniemi et al. 2011). 
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3.1 Age-associated decrease of the ovarian follicle pool 
After puberty, the number of oocytes steadily decreases due to repeated ovulation. A lot of 
oocytes are consumed in 1 estrous cycle, but only a few oocytes are eventually ovulated. In 
humans, only 400 oocytes are dedicated for ovulation throughout the lifespan. During 
aging, the ovarian follicle pool declines continuously, and this is partly because of atresia. 
Resting follicles in humans enter atresia through a necrotic process during the initial 
recruitment phase of folliculogenesis because the ooplasm in those follicles contains 
increasing numbers of multivesicular bodies and lipid droplets, dilation of the smooth 
endoplasmic reticulum and the Golgi apparatus, and irregular mitochondria with changed 
matrix densities (de Bruin et al. 2002; de Bruin et al. 2004). The atresia of ovarian follicles 
during aging may be induced by dysfunctions of proteosomes and the endoplasmic 
reticulum (Matsumine et al. 2008). 
Although most primordial follicles that are initiated to grow are destined to cell death, the 
recruitment of follicles from the resting ovarian follicle pool is the sole method to salvage 
the follicles. FSH is a strong trophic factor that supports both the cyclic recruitment of antral 
follicles and the growth of follicular somatic cells (Chun et al. 1996).  
3.2 Age-associated aberrancies of oocyte chromosomes 
The most deleterious damage in oocytes is often observed in chromosomes. The relationship 
between maternal age and the increased incidence of oocyte aneuploidies has been studied 
in several epidemiological studies (Hassold & Jacobs 1984; McFadden & Friedman 1997; 
Pellestor et al. 2003). In women in their early 20’s, the risk of trisomy in a clinically 
recognized pregnancy is only approximately 2%, whereas it increases up to 35% in women 
in their 40’s (Hassold & Chiu 1985). Supportively, more than half of oocytes from patients of 
advanced age exhibit aneuploidy (Kuliev & Verlinsky 2004; Pellestor et al. 2005). This 
abnormality is believed to occur because of chromosomal nondisjunction during either 
meiosis I or II (Nicolaidis & Petersen 1998; Hassold et al. 2007). The incidence of aneuploidy 
is not random; abnormalities of chromosomes 16 and 22 originate more frequently in 
meiosis II than in meiosis I, and those of chromosomes 13, 18, and 21 occur more frequently 
in meiosis I than in meiosis II (Kuliev et al. 2005). In addition to this nondisjunction theory, 
the premature separation of chromatids during meiosis is suggested to be responsible for 
aneuploidy; the age-associated degradation of cohesins or the other molecules sustaining 
chromatids during metaphase I may contribute to the age-related increase in aneuploidy 
(Watanabe & Nurse 1999).  
3.3 Age-associated decline of mitochondrial activities 
The mitochondria alter their organization, shape, and size, depending on various signals 
(Bereiter-Hahn & Voth 1994). Mitochondrial turnover is the most important process to 
maintain a healthy state of the mitochondria. During this process, they undergo biogenesis 
and degradation (Seo et al. 2010). Mitochondrial biogenesis is enhanced in muscle cells 
under certain physiological conditions such as myogenesis, exercise, cold exposure, 
hypoxia, and calorie restriction (CR) (Freyssenet et al. 1996; Nisoli et al. 2003; Kraft et al. 2006; 
Civitarese et al. 2007; Zhu et al. 2010). Damaged or incompetent mitochondria are removed 
by macroautophagy (Wang & Klionsky 2011).  
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Although whether mitochondrial dynamics are important for the maintenance of oocyte 
integrity during aging remains unclear, the copy number of the mitochondria is one of the 
factors that affect the developmental capacity of oocytes after implantation in mice (Wai et 
al. 2010). In addition, mouse oocytes with artificial mitochondrial damages lost their ability 
to be matured in vitro (Takeuchi et al. 2005). Thus, the oocyte quality is largely dependent on 
mitochondrial health. 
Progressive and accumulative damages to mitochondrial DNA (mtDNA) have been 
postulated to be responsible for the aging process. In aged human fibroblasts, point 
mutations are likely to occur at specific positions in the replication-controlling region 
(Michikawa et al. 1999). Although these specific mutations have never been reported in aged 
human oocytes, several mutations in mtDNA were responsible for the decreased ability of 
oocytes to develop (Barritt et al. 2000). In the report, ooplasmic transfer from young oocytes 
to aged oocytes improved the quality of aged oocytes, indicating that the decreased 
mitochondrial activities in aged oocytes were complemented. 
4. Molecular events during aging 
Oocyte quality declines during aging in a complicated process involving several events  
(Fig. 3). Oxidative stress affects both the size of the ovarian follicle pool and oocyte quality. 
The reduced follicle pool accelerates hormonal dysregulation. This, in turn, promotes the 
decrease in the size of the ovarian follicle pool and oocyte quality. In this section, the recent 
findings regarding the molecular events that occur during reproductive aging are discussed. 
 
Fig. 3. A negative loop leading to the age-associated decline of oocyte quality. Because of 
repeated ovulation and the loss of antioxidants including SOD, catalase, glutathione S-
transferases (GSTs) etc., excess oxidative stress accelerates the decrease of both oocyte quality 
and the size of the follicle pool. The decreased follicle pool results in the insufficient secretion 
of ovarian estrogens and inhibins and the rise of FSH. These changes accelerate the decrease of 
the follicle pool and directly affect oocyte quality. Both oxidative stress and aberrant hormones 
induce the molecular alterations (GSTT1, p-p38 etc.) in oocytes and granulosa cells. 
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4.1 Serum hormone levels 
Full competence of oocytes to develop to term is acquired depending on the proper timing 
of hormonal activation. The decrease in follicle numbers because of aging ensures 
aberrant hormonal regulation as a result of incomplete feedback mechanisms. This 
hormonal dysregulation will, in turn, accelerate the loss of follicles at the advanced age 
(McTavish et al. 2007). 
The most well-known hormones that affect aging are FSH and LH. Under the normal 
conditions, relatively high levels of FSH promote the synthesis of estradiol, inhibin A, and 
inhibin B in granulosa cells (Tonetta & diZerega 1989). On the other hand, LH regulates the 
production of androgens in theca cells of small antral follicles and promotes the conversion 
of androgens to estradiol by aromatization (Erickson et al. 1985). These factors, in turn, 
decrease the serum levels of FSH and LH. With luteal regression, the downregulation of 
estradiol and inhibin A in luteinized granulosa cells allows the rise of FSH again at the onset 
of the subsequent menstrual cycle (Broekmans et al. 2009). Therefore, the negative feedback 
system between the pituitary and the ovary enables follicles to grow properly. 
The dysfunction of the hypothalamic GnRH pulse generators results in an abnormal release 
of FSH and LH from the pituitary around menopause (Wise et al. 1996). However, the factor 
that is critical to induce improper hormonal regulation is the loss of the follicle pool (Fig. 3). 
Decreasing numbers of follicles in the ovaries result in decreasing concentrations of 
circulating estrogens and inhibins during aging (Broekmans et al. 2009). Accordingly, the 
serum concentration of FSH is elevated because of aging (Klein et al. 1996). The hormonal 
changes, especially the decrease in the levels of inhibins, are highly associated with oocyte 
quality (Chang et al. 2002).  
Anti-Mullerian inhibitory hormone (AMH) is expressed in granulosa cells of nonatretic 
preantral and small antral follicles (Baarends et al. 1995). AMH has been postulated to 
regulate the entry of primordial follicles into the growing pool (Durlinger et al. 2002). As the 
number of antral follicles decreases with age, the serum amount of AMH diminishes (van 
Rooij et al. 2004).  
Because these changes are largely associated with the unique features of oogenesis, age-
associated hormonal changes are inevitable. Abnormal levels of hormones can be a risk 
factor for certain diseases other than infertility. For example, elevated FSH levels stimulate 
TNF- synthesis directly from bone marrow granulocytes and macrophages and promote 
osteoporosis in mice (Iqbal et al. 2006; Sun et al. 2006). In addition, the single nucleotide 
polymorphism (SNP) rs6166 of the FSHR gene significantly influences bone mineral density 
in postmenopausal women (Rendina et al. 2010).  
4.2 Oxidative stress and cellular scavengers 
Oxidative stress is generally accepted as the major cause of aging. The major source of ROS 
is believed to be the mitochondria, because ROS are generated as byproducts of electron 
transport during respiration. Although about 1 – 2 % of oxygen in the heart is converted into 
ROS under physiological conditions, ROS generation increases under pathological 
conditions (O'Rourke et al. 2005; Valko et al. 2007). ROS are removed rapidly through 
multiple pathways to protect cells and tissues in normal young individuals.  
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A similar system must be present in the ovaries. Free radical activities in human follicular 
fluid have been shown to be increased during aging (Wiener-Megnazi et al. 2004). However, 
the levels of free radical scavengers, including SOD1, SOD2, and catalase, were significantly 
decreased in the granulosa cells from older women compared with those in the granulosa 
cells from younger women (Tatone et al. 2006). In addition, oxidative damages measured by 
the expression of 8-hydroxydeoxyguanosine were observed in oocytes after ovulation (Chao 
et al. 2005; Miyamoto et al. 2010). Although the ovarian levels of oxidative stress during 
aging remain unclear, excess ROS induced by ovulation may affect the quality of oocytes 
that are stored in the ovaries (Fig. 3). In fact, ovulation induced ROS generation in the 
ovaries, resulting in oxidative damage of genomic DNA and mitochondrial DNA mutations 
(Agarwal et al. 2005; Chao et al. 2005). 
Glutathione (GSH) – a direct ROS scavenger – protects cells from deleterious attacks of ROS. 
Accordingly, it is highly correlated with oocyte quality in terms of viability (Zuelke et al. 
2003; Luberda 2005). However, whether the level of GSH in oocytes from aged females is 
decreased compared with that from young females is unclear.  
GSTs are well-known detoxification factors that excrete genotoxins by conjugation of GSH 
directly to the genotoxins (Sheehan et al. 2001). In addition to this characteristic, some GSTs 
have been shown to play important roles in ROS scavenging by affecting JNK stress 
signaling (Adler et al. 1999; Cheng et al. 2001). As expected from the known functions, GST 
activities in aged oocytes were lower than those in young oocytes (Tarin et al. 2004). We 
previously reported that GSTT1 was upregulated in aged granulosa cells, although the other 
isoforms of GSTs were downregulated (Ito et al. 2008). GSTT1 is known to have bilateral 
features in that it removes toxins and oxidative stress from cells and tissues and it produces 
harmful formaldehyde using halogenated substrates (Sherratt et al. 1998; Landi 2000). 
Although it remains uncertain whether GSTT1 is positively or negatively involved in 
reproductive aging, GSTT1-depleted granulosa cells exhibit mitochondrial 
hyperpolarization, suggesting that GSTT1 plays a role in controlling mitochondrial activities 
(Ito et al., 2011). 
4.3 Genes-related to apoptosis during reproductive aging 
BCL family members are closely related to apoptosis in ovarian cells as well as in other cell 
types (Tilly et al. 1997). Overexpression of BCL-2 in mouse ovaries leads to decreased 
follicular apoptosis (Hsu et al. 1996). A prominent decrease of BCL-2 was also observed in 
eggs aged in vitro (Gordo et al. 2002). In addition, the upregulation of BIM in cumulus cells 
seems to accelerate oocyte aging (Wu et al. 2011). More impressively, ovarian functions in 
mice with genetically engineered BAX were prolonged (Perez et al. 1999). Supporting this 
report, damaged oocytes in mice exhibited higher expression level of BAX (Kujjo et al. 2010). 
Hence, BAX may be a therapeutic target for oocyte rejuvenation. 
4.4 Cellular signaling involved in oocyte survival and death 
The crosstalk of the signal kinases is important for oocyte survival. For the survival of 
primordial follicles, 3-phosphoinositide-dependent protein kinase-1 (PDK1) in oocytes 
preserves the lifespan by maintaining the ovarian follicle pool (Reddy et al. 2009). PDK1 and 
PTEN have been reported to be critical regulators in the phosphatidylinositol 3-kinase (PI3K) 
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signaling pathway (Iwanami et al. 2009). Therefore, the loss of PTEN results in the activation 
and depletion of the primordial follicle pool in early adulthood (Reddy et al. 2008). 
Higher levels of M-phase promoting factors and mitogen-activated protein kinases 
(MAPKs) have been observed in ovulated oocytes from aged mice (Tarin et al. 2004). 
Although how these signaling molecules are involved in oocyte activities remains uncertain, 
JNK, but not p38 MAPK, was found to participate in oocyte fragmentation and 
parthenogenetic activation in aged oocytes (Petrova et al. 2009). 
In our previous report, p38 MAPK in human granulosa cells showed a unique pattern of 
activation and localization during aging (Ito et al. 2010). Because p38 has been shown to 
translocate between the nucleus and cytoplasm upon stimulation (Gong et al. 2010), the 
changes in the subcellular localization of active p38 during aging reflect the 
microenvironmental status around oocytes and granulosa cells. The nuclear localization of 
p38 in young granulosa cells may be due to the proper transactivation of genes in response 
to hormones. On the other hand, the cytoplasmic localization of p38 in aged granulosa cells 
may be resulted from exposure to oxidative stress. Although it is unclear whether or not 
such kind of age-associated changes occurs in oocytes, regulation of activation and 
localization of p38 may contribute to oocyte juvenescence. 
5. Is it possible to rescue age-related infertility? 
5.1 Anti-aging effects of calorie restriction 
Although aged oocytes adapt to the stressful environment and endure multiple disorders 
that occur inside and outside oocytes, they eventually lose their ability to develop to term. Is 
it possible to rejuvenate aged oocytes? Although oocyte rejuvenation should be considerably 
attractive for treatment of age-related infertility, it has not succeeded so far. However, it 
may be possible to prolong ovarian functions (or to delay ovarian aging). Physical 
juvenescence can be achieved with several methods, including calorie restriction (CR), 
moderate fitness and nutritional supply (Prokopov & Reinmuth 2010). These treatments are 
believed to maximize mitochondrial performance and lower the incidence of mitochondrial 
dysfunction (Lopez-Lluch et al. 2006; McKiernan et al. 2007).  
CR has been suggested to elongate the lifespan of many organisms (Wolf 2006). CR 
influences energy metabolism, oxidative damage, inflammation, and insulin sensitivity. CR 
is reported to activate SIRT1, a key factor that regulates longevity (Allard et al. 2009). An 
important role of SIRT1 may be refreshment of damaged mitochondria by inducing 
macroautophagy (Kume et al. 2010). Therefore, CR enhances cellular homeostasis. Apart 
from the beneficial effects of CR on longevity, it was believed to be the cost for reproductive 
capacities (Holliday 1989). Harsh CR (30% or more) is unable to maintain stored oocytes 
enough for their subsequent development, whereas milder CR (20%) resulted in the loss of 
the negative effects on fecundity (Rocha et al. 2007). Recently, CR has been shown to be 
beneficial for maintaining the integrity of oocyte chromosomes in mice (Selesniemi et al. 
2011). These effects were mimicked by the genetic loss of the metabolic regulator, 
peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1). Our 
preliminary data also reveal that CR (approximately 15% reduction of body mass after one 
year of treatment) did not reduce fertility in mice. Rather, the CR-treated mice bore more 
offspring. These data indicate that CR supports the oocyte quality in aged females.  
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Although the hypothesis that physical juvenescence correlates with the maintenance of 
oocyte integrity must be explored further, other treatments that lead to anti-aging may 
support oocyte integrity during aging. 
5.2 Nutritional supports of fertility 
Since CR has been demonstrated to be beneficial for the juvenescence of cells and tissues 
including germ cells, as described above, the daily nutritional intake must be crucial for 
cellular juvenescence. One of the most successful nutrients that affect anti-aging may be 
polyphenols. For example, turmeric-derived tetrahydrocurcumin and green tea polyphenols 
promote longevity of mice (Kitani et al. 2007). Of those polyphenols, resveratrol has been a 
potent therapeutic target for age-related diseases. Resveratrol is found in eucalyptus, 
peanuts, and grapevines (Soleas et al. 1997), and its functional properties are versatile 
probably because of its divergent targets. It has beneficial effects in terms of prevention of 
various cancers, cardiovascular diseases, neurodegenerative diseases, and diabetes in 
animal models (Vang et al. 2011), because of its antioxidant and anti-inflammatory 
properties (Schmitt et al. 2010). Moreover, resveratrol has been demonstrated to prolong 
lifespan in short-lived vertebrates (Valenzano et al. 2006), because it greatly enhances the 
activity of SIRT1 (Howitz et al. 2003; Knutson & Leeuwenburgh 2008). In addition to its anti-
aging properties, resveratrol has been reported to function as estrogen through direct 
association with estrogen-responsive element (ERE) (Klinge et al. 2003). Although the 
beneficial effects of resveratrol in humans remain to be determined, it is expected to be a 
mimetic of CR and have the potential to preserve oocyte quality in aged females. 
Supportively, resveratrol assisted the increase of the ovarian follicle pool in both neonatal 
and aged rat ovaries (Kong et al. 2011). Genistein, one of isoflavones, also seems to increase 
the ovarian follicle pool by inhibiting atresia in aged rats (Chen et al. 2010).  
Royal jelly (RJ) was reported to contribute to the prolongation of longevity in mice (Inoue et 
al. 2003). RJ reduced the damages of DNA by acting as an antioxidant. Similar to resveratrol, 
RJ contains an estrogen-like component that associates with the ERE (Mishima et al. 2005). 
Traditionally, it has been used to treat menopausal symptoms, although the detailed 
mechanism by which RJ treats menopausal disorders is yet to be determined. RJ seems to 
rebalance the hormonal concentration in the blood; it decreased the FSH concentrations and 
increased the estrogen concentrations in aged mice (Fig. 4). These changes, in turn, increased 
the number of ovulated oocytes. This may improve the oocyte quality in aged body, 
although further investigation is required.  
Recently, a probiotic strain, LKM512, present in yogurt was shown to prolong the 
longevity of mice (Matsumoto et al. 2011). LKM512 has been suggested to act on the 
polyamines circulating bodies and result in the unexpected prolongation of longevity. 
Although whether these beneficial effects on longevity can sustain the maintenance of 
oocyte quality remains unclear, some of these nutritional elements may alleviate female 
reproductive aging. 
The exact mechanism by which some anti-aging treatments improve female reproductive 
capacity remains unknown. However, hormonal regulation in aged females becomes similar to 
that in young females with anti-aging treatments, and this is probably due to the prevention of 
follicle loss or the enhancement of hormonal secretion from aged ovaries (Fig. 5).  
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Fig. 4. Effects of RJ on female reproductive capacities. The administration of RJ in drinking 
water to aged female mice (60 weeks old) for 2 months markedly decreased the serum 
concentrations of FSH (a). RJ slightly increased the number of ovulated oocytes (b).  
 
Fig. 5. Age-dependent hormonal regulation in the ovaries. In young females, the negative 
feedback system in the pituitary-gonadal axis is active, and the amount of FSH and LH is 
regulated by estrogens (E2) and inhibins secreted from the ovaries. However, inadequate 
amounts of E2 and inhibins synthesized from aged ovaries cannot decrease the serum levels 
of FSH and LH. These changes can be treated by anti-aging therapies, such as the 
supplemental administration of RJ that may prevent the waste of follicles during ovulation 
or enhance the synthesis of ovarian hormones. 
5.3 Other compounds that affect oocyte aging 
Because oxidative stress promotes reproductive aging, antioxidants can be effective in 
regaining reproductive juvenescence. In fact, oral administration of vitamins C and E could 
prevent age-related ovarian disorders in mice (Tarin et al. 1998a; Tarin et al. 2002). In 
addition, some antioxidants are used to treat infertility (Visioli & Hagen 2011).  
L-cystine, a component of GSH, and -mercaptoethanol decreases oocyte quality to develop 
to the blastocyst stage, whereas dithiothreitol (DTT) enhances the fertilization rate and the 
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developmental capacity of oocytes (Tarin et al. 1998b). Moreover, DTT supports embryonic 
integrity regarding cell number in inner cell mass cells (Rausell et al. 2007). Therefore, 
reagents that assist redox may be effective in enhancing oocyte quality. However, all these 
compounds were tested in oocytes that were aged in vitro, and thus, their reported effects 
may not be observed in oocytes from aged females.  
On the other hand, nitric oxide (NO) seems to be a strong candidate for the treatment of the 
declining oocyte quality in aged females, because the exposure of aged oocytes to  
NO decreased the loss of cortical granules and the frequency of spindle abnormalities (Goud 
et al. 2005). 
6. Future perspectives to achieve the juvenescence of female fertility 
The impact of reproduction on the maternal longevity has been postulated by numerous 
epidemiological and historical studies (Westendorp & Kirkwood 1998; Le Bourg 2007; 
Mitteldorf 2010), and the tradeoff between fertility and longevity may occur through genetic 
or metabolic factors. However, some studies reported a positive correlation between 
maternal age at reproduction and female longevity (Muller et al. 2002; Helle et al. 2005). 
Although the outcomes of those surveys varied, maternal age at the time of the first 
childbirth seems to be positively correlated with female longevity.  
Therefore, the most important factor affecting their fecundity must be physical 
juvenescence. Because the quality of oocytes from women who successfully give birth at 
advanced ages is somehow integral, physical juvenescence can increase oocyte quality 
(chromosomes and cytoplasm), although it may be difficult to increase the number of 
follicles stored in aged ovaries. Regarding longevity, fitness, or CR is successful in several 
species, including humans (Lahdenpera et al. 2004). In addition, some nutritional 
supplements could assist the longevity of animals, as described above. Although it remains 
uncertain whether or not those supplements can improve the integrity of oocytes even after 
aging, these kinds of treatment may help age-associated infertility in the future.  
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